Ursodeoxycholic acid therapy for primary sclerosing cholangitis: Results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

Journal of Hepatology

Volumn 29, Issue 3, 1998, Pages 417-423

  Van Hoogstraten, Hubert J F ^a   Wolfhagen, Frank H J ^a   Van De Meeberg, Paul C ^b   Kuiper, Hillechien ^c   Nix, Gerard A J J ^a   Becx, Marco C J M ^d   Hoek, Aad C ^e   Van Houte, Dennis P F ^f   Rijk, Marco C M ^g   Salemans, Jan M J I ^h   Scherpenisse, Joost ⁱ   Schrijver, Max ^j   Smit, Adelbert M ^k   Spoelstra, Pieter ^l   Stadhouders, Paul H G M ^m   Tan Gie, T ⁿ   Hop, Wim C J ^a   Ten Kate, Fiebo J W ^c   VanBerge Henegouwen, Gerard P ^b   Schalm, Solko W ^a   Van Buuren, Henk R ^a   Van Buuren, Hubert R ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d Ziekenhuis Overvecht   (Netherlands)

^e Van Weel Bethesda Ziekenhuis   (Netherlands)

^f Streekziekenhuis Oranjeoord   (Netherlands)

^g Ziekenhuis de Baronie   (Netherlands)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ REINIER DE GRAAF HOSPITAL   (Netherlands)

^j MEDICAL CENTER HAAGLANDEN   (Netherlands)

^k JEROEN BOSCH HOSPITAL   (Netherlands)

^l Medisch Centrum   (Netherlands)

^m CANISIUS WILHELMINA HOSPITAL   (Netherlands)

ⁿ Streekziekenhuis Midden Twente   (Netherlands)

more..

Author keywords

Bile acid therapy; Cholestatic liver disease; Dose regimen; Histology; Survival

Indexed keywords

URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; LIVER BIOPSY; LIVER FUNCTION TEST; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032171527     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80059-7     Document Type: Article

References (27)

1. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 332:1995;924-933.
2. Broome U, Eriksson LS. Assessment for liver transplantation in patients with primary sclerosing cholangitis. J Hepatol. 20:1994;654-659.
3. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL, Beaver SJ, Zinsmeister AR. Prospective trial of penicillamine in primary sclerosing cholangitis. Gastroenterology. 95:1988;1036-1042.
4. Knox TA, Kaplan MM. A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology. 106:1994;494-499.
5. Olsson R, Broome U, Danielsson A, Hagerstrand I, Jarnerot G, Loof L, et al. Colchicine treatment of primary slerosing cholangitis. Gastroenterology. 108:1995;1199-1203.
6. Leuschner U, Fischer H, Kurtz W, Guldutuma S, Hubner K, Hellstern A, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology. 97:1989;1268-1274.
7. UDCA-PBS Study Group Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med. 324:1991;1548-1554.
8. O'Brien CB, Senior JR, Arora-Mirchandani R, Batta AK, Salen G. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. Hepatology. 14:1991;838-847.
9. Chazouilleres O, Poupon R, Capron JP, Metman EH, Dhumeaux D, Amouretti M, et al. Ursodeoxycholic acid for primary sclerosing cholangitis. J Hepatol. 11:1990;120-123.
10. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, et al. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatology. 16:1992;707-714.
11. Stiehl A, Walker S, Stiehl L, Rudolph G, Hofmann WJ, Theilmann L. Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. J Hepatol. 20:1994;57-64.
12. Mitchell S, Bansi D, Hunt D, Christie J, Fleming K, Chapman R. High dose ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC): results after two years of a randomised double-blind, placebo-controlled trial [abstract]. Gastroenterology. 112:1997;1335. (Suppl).
13. Lindor KD. Ursodiol for primary sclerosing cholangitis. N Engl J Med. 336:1997;691-695.
14. van de Meeberg PC, Wolfhagen FHJ, van Berge Hengouwen GP, Salemans JMJI, Tangerman A, van Buuren HR, et al. Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response. J Hepatol. 25:1996;887-894.
15. Lacerda MA, Lindor KD, Jorgensen RA, Rossi S, Hoffmann A, Dickson ER. Ursodiol in primary biliary cirrhosis (PBC): enrichment correlates with biochemical improvement [abstract]. Hepatology. 104:1993;933.
16. Jorgensen RA, Dickson ER, Hofmann AF, Rossi SS, Lindor KD. Characterisation of patients with a complete biochemical response to ursodeoxycholic acid. Gut. 36:1995;935-938.
17. Colombo C, Crosignani A, Assaisso M, Battezzati PM, Podda M, Giunta A, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatitis. 16:1992;924-930.
18. Walker S, Rudolph G, Raedsch R, Stiehl A. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage. Gastroenterology. 102:1992;810-815.
19. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Br Med J. 2:1955;1041-1048.
20. Hodgson HJ, Mazlam MZ. Review article: assessment of drug therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 5:1991;555-584.
21. Ludwig J, Barham SS, LaRusso NF, Elveback LR, Wiesner RH, McCall JT. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology. 1:1991;632-640.
22. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver. 13:1993;113-122.
23. Kim WR, Therneau TM, Wiesner RH, Malinchoc M, Kaplan MM, Williams R, et al. A revised natural history model for primary sclerosing cholangitis obviates the need for liver histology [abstract]. Hepatology. 26:1997;362.
24. Chen LY, Goldberg HI. Sclerosing cholangitis: broad spectrum of radiographic features. Gastrointest Radiol. 9:1984;39-47.
25. Majoie CB, Reeders JW, Sanders JB, Huibregtse K, Jansen PLM. Primary sclerosing cholangitis: a modified classification of cholangiographic findings. Am J Roentgenol. 157:1991;495-497.
26. Craig DA, MacCarty RL, Wiesner RH, Grambsch PM, LaRusso NF. Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. Am J Roentgenol. 157:1991;959-964.
27. Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci. 34:1989;59-65. (suppl).